诊室KTP激光治疗遗传性出血性毛细血管扩张症相关鼻出血
回顾性病例系列评估诊室KTP激光治疗遗传性出血性毛细血管扩张症(HHT)相关鼻出血的疗效与安全性。16例成人患者治疗后鼻出血严重度评分(ESS)从基线7.24降至随访4.92,差异有临床和统计学意义,无不良事件或并发症。
要点
- 诊室KTP激光可显著降低HHT患者ESS评分。
- 16例患者均未报告不良事件或并发症。
- 平均疼痛评分0.19,多数患者术中无出血。
核心结论
- 诊室KTP激光光凝治疗后HHT患者ESS评分出现有临床和统计学意义的下降,患者耐受良好,无不良事件或并发症。
主要发现
- ESS基线7.24(SD 1.71),随访4.92(SD 1.83),平均差2.94(95%CI 1.83-4.04,P<.0001)。
- 无报告与操作相关的不良事件或并发症。
- 平均疼痛评分0.19(SD 0.75),平均失血量10.8 mL(SD 37.3),62.5%(10/16)患者术中无失血。
临床怎么用
- 诊室KTP激光可作为成人HHT相关鼻出血的一种耐受性良好的治疗选择。
局限性
- 回顾性病例系列,样本量16例,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluated the efficacy and safety of in-office potassium titanyl phosphate (KTP) laser treatment for the management of epistaxis in hereditary hemorrhagic telangiectasia (HHT) patients. METHODS: A retrospective case series of all HHT patients over age of 18 who underwent in-office KTP laser treatment from July 1, 2017 to December 31, 2019 was performed. The primary outcome measure was the epistaxis severity score (ESS) pre- and post-procedure. Secondary outcome measures included patient reported pain (on a 10-point Likert-type scale), and procedural adverse events and complications. RESULTS: A total of 16 patients underwent KTP in-office laser treatment during the review period. There was both a clinically and statistically significant decrease in the ESS after in-office laser treatment, baseline ESS -7.24, SD 1.71, follow up ESS -4.92, SD 1.83 (mean difference 2.94, 95% confidence interval, 1.83-4.04, P < .0001). There were no reported adverse events or complications associated with the procedure. The mean pain score reported was 0.19, SD 0.75. The average blood loss was 10.8 mL, SD 37.3. The majority of patients (62.5%, 10/16) had no blood loss during the procedure. CONCLUSION: Clinically and statistically significant decreases were noted in the ESS of HHT patients after in-office KTP laser photocoagulation. The procedure was well tolerated by patients, without any adverse events or complications. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E689-E693, 2021.
引用
- Wu V, Kell E, Faughnan ME, et al. In-Office KTP Laser for Treating Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis. Laryngoscope. 2020. PMID: 32557619. doi:10.1002/lary.28824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。